Joe Haydamous

Mr. Joe Haydamous

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2025 in Journal of Medical Education and Curricular Development
Verified
Journal Article
Open access
MSMohd Faizan Siddiqui
Mohd Faizan Siddiqui
SJSheeda Jabeen
Sheeda Jabeen
AAAmenah Alwazzan
Amenah Alwazzan
SVSebastiano Vacca
Sebastiano Vacca
LDLara Dalal
Lara Dalal
RKRoman Kalmatov
Roman Kalmatov
Objective: Augmented reality (AR) is a technology that incorporates digital information into user's physical surroundings. It represents a paradigm shift in medical treatment and education. AR aides in surgical planning and patient therapy, as well as assisting patients in comprehending difficult medical problems. AR is evident in several facets of medicine, and there is a significant need for helping systems as a result of the increasing stress placed on public health systems during pandemics. The use of virtual reality (VR) and AR in surgery, dentistry, telemedicine, self-care, and wellness treatments has already improved many areas of healthcare. Method: This systematic review adheres to Preferred Reporting Items for Systematic Reviews and Meta-Analysis checklist and was conducted using PubMed and Scopus databases with keywords such as “Augmented Reality (AR),” “Virtual Reality (VR),” “Extended Reality (XR),” “Medical Education,” “Surgical Planning,” “Clinical Training,” and “Patient Therapy.” Boolean operators (AND, OR) were applied, and through a systematic review process, 21 peer-reviewed studies published between 2010 and 2024 were analyzed. Results: The usage of ARs and VRs in medical education is of great interest since they blend physical and digital learning features. Of the 21 studies (2021-2024), 8 systematic reviews and 3 randomized controlled trials showed that XR was effective in medical education (5 studies) and surgical planning (4 studies). Six studies identified low- and middle-income countries’ limitations (eg, costs, infrastructure), but one research found that non-XR approaches were successful in resource-limited locations. Common drawbacks were limited sample sizes (3 studies) and database biases (2 studies). XR showed transformational potential but needed equitable scalability techniques. Conclusion: The primary goal of this systematic review is to provide insight into AR research, identify potential future trends, and serve as inspiration for healthcare professionals, medical college professors, researchers, and scientists working in the fields of AR, VR, and XR in the healthcare industry.

8 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ЕБЕвгения Leonidovna Бабунашвили
Евгения Leonidovna Бабунашвили
DSDanil Yurievich Son
Danil Yurievich Son
SBSvetlana Nikolaevna Buyanova
Svetlana Nikolaevna Buyanova
NSNatalya Alekseevna Schukina
Natalya Alekseevna Schukina
APAlexander Anatolyevich Popov
Alexander Anatolyevich Popov
AEAndrea Etrusco
Andrea Etrusco
Background: The incidence of pregnant women with uterine fibroids is increasing. As they are reactive to hormonal stimuli, in some cases, uterine fibroids tend to grow during pregnancy and potentially generate symptoms with different levels of severity, causing maternal–fetal complications. In very select cases, when other treatment strategies fail to manage symptoms and there is a substantial risk of adverse pregnancy outcomes, a surgical approach during pregnancy may be considered. Methods: From 2016 to 2021, the data from 28 pregnant women with symptomatic uterine fibroids who underwent laparotomic myomectomy during pregnancy were prospectively collected, and operative and maternal–fetal outcomes were analyzed (ClinicalTrial ID: NCT06009562). Results: The procedure was carried out between 14 and 16 weeks of pregnancy. Four (14.3%) patients had intraoperative complications (miscarriages) and nine (32.1%) had postoperative complications (threatened preterm birth). Overall, 24 (85.7%) women delivered at full term (mean: 38.2 gestational weeks), more than half (n = 13; 54.2%) by vaginal delivery, with normal fetal weights and 1 and 5 min Apgar scores. Conclusions: Laparotomic myomectomy during pregnancy can be considered in selected cases for uterine fibroids with severe symptoms when other treatment options have failed and there is high risk of adverse maternal–fetal outcomes.

Verified
Journal Article
Open access
PDF file
EFEdwin Feghali
Edwin Feghali
AEAndrea Etrusco
Andrea Etrusco
JHJoe Haydamous
Joe Haydamous
AAAmal Ayed
Amal Ayed
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
ZSZaki Sleiman
Zaki Sleiman
Background: Adenomyosis and congenital uterine anomalies (CUAs) can compromise reproductive potential and may coexist in the same patient, especially in cases of infertility. This review (CRD42022382850) aims to evaluate the published cases of concurrent adenomyosis and syndromic and nonsyndromic CUAs. Methods: A literature search for suitable articles published in the English language was performed using the following databases from inception to 30 November 2022: MEDLINE, EMBASE, Global Health, the Cochrane Library, Health Technology Assessment Database, and Web of Science. Articles including both CUAs and adenomyosis, with data about their potential relationship, were included. Results: The literature search retrieved 14 articles that met the purpose of this review and summarized the most recent findings regarding the concurrent diagnosis of adenomyosis and CUAs. Conclusions: Adenomyosis can be found in both syndromic and nonsyndromic CUAs, and may arise from several etiologies. The hypothesis that obstructions in CUAs increase uterine pressure and promote the development of adenomyosis remains to be further elucidated, and additional findings may also play a role. The patient’s genetic, epigenetic, and hormonal patterns, as well as normal physiological processes, such as pregnancy, may influence the growth of adenomyosis.

17 August 2026 in Pregnancy
Verified
Journal Article
Open access
PDF file
JHJoe Haydamous
Joe Haydamous
MGMadelyn Guerra
Madelyn Guerra
SSSelena Salazar
Selena Salazar
RBRosa Burroughs
Rosa Burroughs
KEKayla Evans
Kayla Evans
ISIrene A. Stafford
Irene A. Stafford
Introduction: Emergency departments (EDs) offer a critical opportunity to identify syphilis during pregnancy. However, patient factors that influence test uptake and follow‐up remain understudied. This study evaluates the role of social determinants of health (SDOH) in syphilis test completion and linkage to prenatal care among pregnant ED patients. Methods: After Institutional Review Board approval, a prospective cohort study was conducted at the University of Texas Health Science Center in Houston, TX. Pregnant patients presenting to the ED between November 5, 2024 and June 1, 2025 were offered opt‐out syphilis testing and linkage to prenatal care. Key SDOH variables included race/ethnicity, primary language, insurance type, prenatal care status, partner presence, and substance use. Multivariable logistic regression identified predictors of test completion and prenatal care follow‐up. Results: Of 230 patients approached, 181 (78%) underwent testing. Hispanic patients were significantly more likely to complete testing than non‐Hispanic White patients (odds ratio [OR], 13.6; 95% confidence interval [CI], 1.5–308.6; p = 0.036), while patients who identified Spanish as their primary language were less likely (OR, 0.11; 95% CI, 0.006–0.68; p = 0.046). Patients without prenatal care were more likely to complete testing (OR, 0.31; 95% CI, 0.14–0.66; p = 0.003), and those with Medicaid (OR, 0.38; 95% CI, 0.16–0.87; p = 0.024) or self‐pay status (OR, 0.19; 95% CI, 0.07–0.50; p = 0.001) were less likely to complete testing compared to privately insured patients. Among tested participants, 88 (49.4%) followed up with prenatal care. Patients who identified Spanish as their primary language (OR, 0.24; 95% CI, 0.08–0.69; p = 0.010) and self‐pay patients (OR, 0.13; 95% CI, 0.04–0.36; p < 0.001) had lower odds of follow‐up. Prenatal care, partner presence, and substance use were not significantly associated with testing completion or follow‐up prenatal visits. Conclusion: Preferred language, insurance status, and ethnicity impact test uptake and prenatal care follow‐up. Addressing these communication and financial barriers may help reduce disparities in perinatal syphilis care.

3 August 2026 in Pregnancy
Verified
Journal Article
Open access
PDF file
ZDZakaria Doughan
Zakaria Doughan
YBYossi Bart
Yossi Bart
JHJoe Haydamous
Joe Haydamous
LDLaura Diab
Laura Diab
Sara GiulianoSara Giuliano
Sara Giuliano
BSBaha M. Sibai
Baha M. Sibai
Background: Expectant management of early‐onset preeclampsia with severe features (<34 weeks’ gestation) requires close maternal surveillance. Although serial testing is routinely performed, recommendations regarding testing frequency vary across professional societies and the clinical utility and financial impact of frequent testing during expectant management remain uncertain. Objective: To describe the role of serial blood tests in guiding delivery decision‐making in preeclampsia with severe features, and to assess the health costs of these serial blood tests. Study Design: A retrospective cohort study of singleton pregnancies diagnosed with preeclampsia with severe features between 23 and 33 weeks at a level IV academic maternity center. Patients with contraindications to expectant management were excluded. Delivery indications were categorized by the contribution of blood test abnormalities: no abnormal blood tests contributing to delivery; blood test abnormalities detected once the decision for delivery was made, but not indication for delivery; and blood test abnormalities as the indication for delivery. Primary outcome was delivery prompted by abnormal blood test findings. Secondary outcomes included charges associated with serial testing. Data analysis included percent with 95% confidence intervals (CIs) or median with interquartile ranges (IQRs). Results: A total of 370 patients met inclusion criteria. Only five (1.4%; 95% CI, 0.4–3.1) had abnormal blood test values (transaminitis and/or thrombocytopenia) prompting delivery decisions, all appearing within 4 days of admission. Abnormal blood testing was not an indication for delivery for most patients ( N = 325; 87.8%; 95% CI, 84.1–91.0). For 40 patients (10.8%; 95% CI, 7.8–14.4), blood test abnormalities were detected after decision for delivery was made. The median number of blood tests per patient was 10 (IQR 6–14), and blood testing charge per patient was $5030 (IQR 3018–7042). The total charge for blood testing was $2.176 million over the study period. Conclusion: Among 370 patients with early‐onset preeclampsia with severe features managed expectantly, only 1% of the cohort had blood test abnormalities as the sole indication for delivery. All other patients were delivered either because of maternal‐fetal indications or developed blood test abnormalities occurring in association with other indications for delivery. Finally, serial blood testing in this setting resulted in total charges of $2.176 million over 9 years. Based on this large cohort, there is a need to reconsider the frequency of blood testing in the absence of new‐onset symptoms or worsening severe features.